Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis
Science Advances · 2026
DOI: 10.1126/sciadv.aeh8222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Paeton L Wantuch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Neonatal Sepsis, Polysaccharides, Bacterial. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Themen: Sepsis
Abstract (Originalsprache)
Klebsiella pneumoniae is the leading cause of neonatal sepsis in low- and middle-income countries and the foremost cause of infectious deaths in young children. K. pneumoniae isolates are becoming increasingly resistant to antibiotics, creating a great need for additional therapies or preventative strategies. Maternal vaccination serves as an attractive approach to protect from K. pneumoniae neonatal sepsis. Herein, we report a murine model of maternal immunization followed by pup challenge to evaluate putative K. pneumoniae vaccines. Dams were immunized with capsular polysaccharide bioconjugate vaccines at mating and boosted with two different immunization schedules throughout the gestational period. After parturition, offspring were tested for antigen-specific antibody levels and later challenged with a lethal dose of K. pneumoniae. Pups born to dams immunized with K1- and K2-conjugate vaccines demonstrated significant protection from sepsis relative to control pups. Antibodies transferred from vaccinated dams persisted and remained protective in pups for at least six weeks after birth. Collectively these results demonstrate a feasible and reproducible murine model of maternal immunization verifying the efficacy of bioconjugate vaccines in protecting against lethal neonatal K. pneumoniae infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Omniose, St. Louis, MO 63110, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
ORCID-Profile: Paeton L Wantuch, Jessica Tung, Isra Darwech, Christian M Harding, Drew J Schwartz, David A Rosen
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Department of Pediatrics, Washington University School of Medicine
- Gates Foundation
Zitieren
APA
Wantuch, P. L., Tung, J., Robinson, L. S., Darwech, I., Knoot, C. J., Harding, C. M., Schwartz, D. J., & Rosen, D. A. (2026). Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis. Science Advances. https://doi.org/10.1126/sciadv.aeh8222
Vancouver
Wantuch PL, Tung J, Robinson LS, Darwech I, Knoot CJ, Harding CM, et al. Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis. Science Advances. 2026. doi:10.1126/sciadv.aeh8222
BibTeX
@article{Wantuch2026,
author = {Wantuch, Paeton L and Tung, Jessica and Robinson, Lloyd S and Darwech, Isra and Knoot, Cory J and Harding, Christian M and Schwartz, Drew J and Rosen, David A},
title = {Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh8222}
}
EUVIMED